Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
China · Delayed Price · Currency is CNY 15.77
+0.43 (2.80%)
Feb 4, 2026, 3:04 PM CST
SHE:300452 Revenue
Anhui Sunhere Pharmaceutical Excipients had revenue of 225.66M CNY in the quarter ending September 30, 2025, with 16.06% growth. This brings the company's revenue in the last twelve months to 934.72M, up 10.85% year-over-year. In the year 2024, Anhui Sunhere Pharmaceutical Excipients had annual revenue of 882.57M with 5.16% growth.
Revenue (ttm)
934.72M
Revenue Growth
+10.85%
P/S Ratio
3.82
Revenue / Employee
877.67K
Employees
1,065
Market Cap
3.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 882.57M | 43.31M | 5.16% |
| Dec 31, 2023 | 839.26M | 134.73M | 19.12% |
| Jan 1, 2023 | 704.53M | 87.82M | 14.24% |
| Dec 31, 2021 | 616.71M | 85.51M | 16.10% |
| Dec 31, 2020 | 531.20M | 67.13M | 14.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.79B |
| PKU HealthCare Corp.,Ltd. | 1.76B |
| Nanjing Well Pharmaceutical Group | 1.31B |
| Hunan Hansen Pharmaceutical | 1.05B |
| Harbin Medisan Pharmaceutical | 874.60M |
| Jiangxi Synergy Pharmaceutical | 825.20M |
| Zhejiang Cheng Yi Pharmaceutical | 790.86M |
| Baotou Dongbao Bio-Tech Co.,Ltd | 784.62M |